No Data
FDA And Nuwellis Address Potentially High-Risk Issue With Blood Circuit Device
Nuwellis Regains Compliance With Nasdaq Listing Requirements
On December 11, 2024, Nuwellis Sent A Notice To Affected Customers That It Is Voluntarily Recalling Specific Lots Of AquaFlexFlow UF 500 Plus Extracorporeal Blood Circuit Which Is Used With The Aquadex Smartflow Or Aquadex Flexflow System - Filing
Express News | Nuwellis Inc - Aware of 5 Reported Incidents of Blood Circuit Failures, Three Leading to Dehydration
Express News | Nuwellis Inc - Announces Voluntary Recall of Specific Lots of Aquaflexflow Uf 500 Plus Extracorporeal Blood Circuit
Nuwellis Files to Sell 3.73M Shares of Common Stock for Holders
No Data
